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appealing hypothesis that early postoperative luminal
nutrition might have a beneficial effect on the function
of the intestinal barrier in respect of permeability, bac›
terial translocation, and the subsequent development
of septic complications has no supporting evidence at
present.
What impact could the findings of this systematic
review have on daily surgical practice? The review
shows that there is no clinical benefit to starving
patients in the early postoperative period after gastro›
intestinal resection. Further, the finding that post›
operative infections can be reduced and hospital stay
shortened by starting early postoperative enteral nutri›
tion should challenge clinicians to consider this
treatment. The findings pave the way for an appropri›
ate multicentred trial to assess early enteral feeding in
patients undergoing elective gastrointestinal resection.
The patients recruited to such a trial should be
stratified by nutritional status and type of surgical pro›
cedure. The outcome measures should include not just
effects on wound infection, other infectious complica›
tions, and dehiscence of the anastomosis but also
surgical fatigue, muscle function, quality of life after
discharge from hospital, and cost effectiveness.
D B A Silk consultant physician
N Menzies Gow consultant surgeon
Department of Gastroenterology and Nutrition, Central Middlesex
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Equity versus efficiency: a dilemma for the NHS
If the NHS is serious about equity it must offer guidance when principles conflict
Concerns about equitable provision and financ›ing of health care have characterised the NHSsince its foundation. Evidence of persisting
and, in some cases, widening health inequalities,
gathered since the publication of the Black report,1 has
progressively raised equity to a high rank among
health policy objectives.2 Though the general aim of
reducing health inequalities appears uncontroversial,
the practical notions of equity that should inform
policy and the ways in which these should be
implemented are far from clear. Even more impor›
tantly, there is no consensus on how to deal with poli›
cies that may cause a conflict between the goals of
equity and efficiency—that is, those that may improve
efficiency while increasing health inequalities or
improve fairness while decreasing efficiency. The
equity versus efficiency dilemma3 has been virtually
ignored in the political debate, often leading to incon›
sistent judgments in the development of health
policies.
In a report recently published by the NHS Health
Technology Assessment programme4 we examined
examples of the equity›efficiency dilemma that the
NHS is facing. The analysis of three case studies—
cervical cancer screening, renal transplantation, and
neonatal screening for sickle cell disease—shows
inconsistencies between NHS policies and a lack of
guiding principles to support the pursuit of equity in
health care.
The NHS policy on cervical cancer screening has
been primarily aimed at maximising coverage by using
powerful economic incentives to general practitioners.
The issue of low participation by women at high risk5
(particularly those in disadvantaged socioeconomic
groups6) has been less of a concern. The programme
could have achieved the same cost effectiveness with
less extensive but more even coverage. The number of
cases of invasive cancer avoided in 1997 is likely to be
60›85% of the number of cases that might have been
avoided if screening rates had increased uniformly in
different social groups after the introduction of target
payments to general practitioners.4 The equity
principle underlying this NHS policy is one of equal
access (rather than outcome) for all women, where
access is defined purely from the perspective of the
healthcare provider.
Renal transplantation consistently generates health
improvements and economic savings, but kidneys are
in short supply and priorities for access to this service
must be set. The UK Donor Kidney Allocation
Scheme7 provides an allocation algorithm in which the
recipient’s age plays an important part. Priority is given
to recipients aged 0›17 over those 18 and older, and
within the older group a decreasing priority is
associated with increasing age. Younger recipients are
favoured in the allocation of younger donors’ kidneys,
with greater survival benefits. These age priorities are
not fully supported by evidence on effectiveness8 and
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efficiency9 grounds, but—of more relevance for our
purposes—not even on equity grounds, as some studies
have shown that the public would rank older children
over younger ones.10 11 Although explicitly formulated
in some respects, this NHS policy again appears to lack
a clear reference to a guiding equity principle.
Sickle cell disease disproportionately affects certain
ethnic minority groups. The UK Standing Medical
Advisory Committee recommended the use of univer›
sal, rather than selective, neonatal screening policies
when ethnic minorities with a high risk comprise more
than 15% of the population.12 At this threshold the cost
of universal screening is as high as £430 000 to £1m
per life year saved (depending on the ethnic minority
mix) compared with selective screening.4 The adoption
of universal screening does not appear to be justified
by concerns for equity across ethnic groups, as the
benefits to the white northern European majority
would still be very small. Rather, it aims at reducing the
number of cases missed because of inaccuracies in the
selection. This NHS policy may reflect an aspiration to
equal access for equal need, but one pursued at a very
high cost. Significant efficiency gains may be sacrificed
for what seems to be an inappropriate conception of
equity in this context.
More examples of inconsistency can be found
among current NHS policies, and even greater
variation could be unveiled. But is it realistic to expect
health policymakers to develop sound and consistent
policies in the absence of evidence about the distribu›
tional effects of healthcare provision? Is it realistic to
expect them to address the equity versus efficiency
dilemma? A systematic review of the literature on
healthcare economic evaluations published in 1987›
974 shows a complete neglect of the equity dimension
within the studies surveyed. Not only did these studies
fail to incorporate equity measures in their cost
effectiveness calculations, they did not even provide
enough information for decision makers to make their
own judgments about the distributional impact of
given policies—for example, on the characteristics of
the population affected by the policy or on the policy’s
effectiveness and cost effectiveness in subgroups.
Our three case studies show the lack of a clear and
consistent definition of equity and the failure to strike
an acceptable balance between the policy goals of
equity and efficiency when these conflict. In different
ways researchers and policymakers share responsibility
for the inconsistent pursuit of equity in the NHS.
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Screening for prostate cancer in the UK
Seems to be creeping in by the back door
Screening for prostate cancer is controversial.Findings from systematic and other reviews con›sistently conclude that there is insufficient
evidence to recommend its introduction because of
concerns that it may not improve survival or quality of
life and may thus cause more harm than good.1–3 Cur›
rent government policy in the United Kingdom,
expressed in the NHS prostate cancer programme,
confirms this view, but adds that “any man considering
a PSA [prostate specific antigen] test will be given
detailed information to enable him to make an
informed choice about whether to proceed with a test
or not.”4 This implies that asymptomatic men may have
the test if they want, so there is now ambiguity about
whether screening is supported and confusion about
what this policy means in practice.
The assumption may be that most men will not
want to be tested once they are informed of the uncer›
tainties. In the United States several studies have shown
that informed choice can reduce prostate specific anti›
gen testing in some groups by up to one half.5–7 But this
may not apply in the United Kingdom. A systematic
review of the use of decision aids has shown that
though such aids result in higher levels of knowledge,
they have variable effects on the decisions themselves,
with reduced preferences for prostate specific antigen
testing found in two studies but no effect in two others.8
Further, close inspection of the landmark study5 shows
that though prostate specific antigen testing was
reduced by half among scheduled clinic attenders who
viewed a video, a parallel (rarely quoted) trial found
that only 3 out of 206 men attending free prostate spe›
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